FAS is likely not the only gene with epigenetic dysregulation in osteosarcoma, and further work must be done to comprehensively evaluate the methylome of osteosarcoma patients and integrate it with other genomic platforms for a more comprehensive understanding of osteosarcoma tumor biology. The gene discussed is FAS; the disease is neoplasm.